Mammalian-type glycosylation in plants by expression of a zebrafish glycosyltransferase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9745594
APP PUB NO 20150176020A1
SERIAL NO

14341296

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to non-mammalian β-1,4-galactosyltransferases that can be used in their wild-type or in modified forms. The invention further relates to transformed plants and plant cells expressing non-mammalian β-1,4-galactosyltransferases and methods to produce glycoproteins with altered and preferably mammalian-type glycosylation. The invention additionally provides nucleic acid molecules and expression vectors of non-mammalian β-1,4-galactosyltransferases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
STICHTING DIENST LANDBOUWKUNDIG ONDERZOEKDROEVENDAALSESTEEG 4 WAGENINGEN NL-6708 PB

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bosch, Hendrik Jan Wageningen, NL 31 369
Florack, Dionisius Elisabeth Antonius Wageningen, NL 16 269
Rouwendal, Gerard Johan Adolph Heteren, NL 7 106

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 28, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 28, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00